Cardiome Pharma Corp (NASDAQ:CRME)

Data as of 4:00pm ET
 -0.01 / -0.10%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world. Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. Cardiome Pharma was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Contact Information

Cardiome Pharma Corp.
6190 Agronomy Road
Vancouver British Columbia V6T 1Z3
P:(604) 677-6905
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

William L. HunterPresident, Chief Executive Officer & Director
Sheila M. GrantChief Operating Officer
Jennifer ArchibaldChief Financial Officer
Karim F. LaljiChief Commercial Officer
Steen Juul-MöllerMedical Director-Europe

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.